---
annotation-target: blood.2022016923.pdf
---


>%%
>```annotation-json
>{"created":"2022-09-16T09:27:18.381Z","updated":"2022-09-16T09:27:18.381Z","document":{"title":"blood.2022016923.pdf","link":[{"href":"urn:x-pdf:eb910ac47bb1031fa160f46ca67cf947"},{"href":"vault:/hematology-theroy/papers/20220916/blood.2022016923.pdf"}],"documentFingerprint":"eb910ac47bb1031fa160f46ca67cf947"},"uri":"vault:/hematology-theroy/papers/20220916/blood.2022016923.pdf","target":[{"source":"vault:/hematology-theroy/papers/20220916/blood.2022016923.pdf","selector":[{"type":"TextPositionSelector","start":7273,"end":7770},{"type":"TextQuoteSelector","exact":"Asparaginases are part of the cornerstone of ALL therapy, but global shortages of Erwinia-derived asparaginases have resulted in reduced availability. To overcome this, JZP458, a recombinant form of Erwinia chrysanthemi asparaginase derived from a novel Pseudomonas fluorescens expression platform was developed. This study showed that intramuscular JZP458 is efficacious and safe and provides a reliable treatment option for patients who develop hypersensitivity to E. coli-derived asparaginases.","prefix":"L/LBL.  Explanation of Novelty  ","suffix":"      Downloaded from http://ash"}]}]}
>```
>%%
>*%%PREFIX%%L/LBL.  Explanation of Novelty%%HIGHLIGHT%% ==Asparaginases are part of the cornerstone of ALL therapy, but global shortages of Erwinia-derived asparaginases have resulted in reduced availability. To overcome this, JZP458, a recombinant form of Erwinia chrysanthemi asparaginase derived from a novel Pseudomonas fluorescens expression platform was developed. This study showed that intramuscular JZP458 is efficacious and safe and provides a reliable treatment option for patients who develop hypersensitivity to E. coli-derived asparaginases.== %%POSTFIX%%Downloaded from http://ash*
>%%LINK%%[[#^5kltbb5znu|show annotation]]
>%%COMMENT%%
>
>%%TAGS%%
>
^5kltbb5znu
